Jones Trading Initiates Coverage On Intellia Therapeutics With Buy Rating, Announces Price Target of $41
Jones Trading Initiates Coverage On Intellia Therapeutics With Buy Rating, Announces Price Target of $41
Jones Trading開始對Intellia Therapeutics進行買入評級，並宣佈目標價格爲$41。
Jones Trading analyst Debanjana Chatterjee initiates coverage on Intellia Therapeutics (NASDAQ:NTLA) with a Buy rating and announces Price Target of $41.
Jones Trading的分析師Debanjana Chatterjee發起對Intellia Therapeutics（納斯達克: NTLA）的覆蓋，並給予買入評級，宣佈股價目標爲41美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間